文献速递慢性肾脏病

基于人群的eGFR分布与健康结局为CKD早期识别和一级预防提供机会

Population-based estimated Glomerular Filtration Rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease.
PubMed 文献 · Kidney Int · 2026-01-16

该研究基于瑞典斯德哥尔摩2006至2021年1,179,501名40-100岁成人、6,914,993次年度eGFR测量,按年龄和性别计算eGFR分布。发现低于第25百分位的eGFR与肾脏替代治疗肾衰竭(KFRT)和死亡风险增加相关,且高百分位亦与死亡风险增加相关;eGFR≥60 ml/min/1.73 m2但低于第25百分位者仅24%接受白蛋白尿检测。基于人群的eGFR图表可能补充自动报告系统,助力CKD早期识别和一级预防。

要点

  • 按年龄和性别构建的eGFR百分位分布可识别低于第25百分位的高风险个体。
  • 低于第25百分位的eGFR与KFRT风险增加相关,低和高百分位均与死亡风险增加相关。
  • eGFR≥60 ml/min/1.73 m2但低于第25百分位者中仅24%接受白蛋白尿检测。

核心结论

  • 低于人群eGFR分布第25百分位的eGFR值与肾脏替代治疗肾衰竭(KFRT)和死亡风险增加相关。
  • 基于人群的eGFR图表可能补充当前自动报告系统,为CKD早期识别和一级预防提供机会。

研究设计与样本

  • 基于人群的观察性队列研究,纳入2006至2021年瑞典斯德哥尔摩40至100岁接受常规血清/血浆肌酐检测的成人。
  • 队列包含1,179,501名独特个体(占该地区80%人口),共6,914,993次重复年度eGFR测量。
  • 按年龄和性别计算eGFR分布后,采用病因特异性Cox回归评估eGFR百分位与KFRT和死亡风险的关联。

主要发现

  • eGFR中位数(2009 CKD-EPI)随年龄增高而降低:40岁时男性104-106 ml/min/1.73 m2、女性104-106 ml/min/1.73 m2,100岁时为45-50 ml/min/1.73 m2。
  • 排除特定共病人群或对未检测人群进行调整对eGFR分布影响极小。
  • 与中心百分位(47.5-52.5th)相比,低于第25百分位的eGFR与KFRT风险增加显著相关,低和高eGFR百分位均与死亡风险增加相关,且各年龄组关联一致。
  • 在421,547名eGFR≥60 ml/min/1.73 m2且低于第25百分位的个体中,仅24%在相邻年份接受白蛋白尿/蛋白尿检测。

关键数值与推荐

  • eGFR低于人群分布第25百分位被定义为风险升高阈值,与KFRT和死亡风险增加相关。
  • eGFR中位数在40岁时为104-106 ml/min/1.73 m2(男性-女性),在100岁时为45-50 ml/min/1.73 m2。
  • eGFR≥60 ml/min/1.73 m2但低于第25百分位者中仅24%接受白蛋白尿/蛋白尿检测。

临床怎么用

  • 可利用按年龄和性别构建的eGFR百分位分布图辅助识别低于第25百分位的高风险个体。
  • 对eGFR低于第25百分位者应考虑进一步诊断评估,包括白蛋白尿/蛋白尿检测。
  • 基于人群的eGFR图表可作为当前自动报告系统的补充工具,支持CKD早期识别和一级预防。

局限性

  • 研究为观察性队列设计,无法确立因果关系。
  • 研究基于瑞典斯德哥尔摩地区人群,外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There are currently no established strategies for early identification and primary prevention of chronic kidney disease (CKD). Automatic reporting of estimated glomerular filtration rate (eGFR) allows opportunistic CKD screening. Here, we hypothesized that comparison with population-based eGFR distributions may further help identify individuals at elevated risk. METHODS: A population-based observational cohort study including adults aged 40 to 100 years with routine serum/plasma creatinine tests (Stockholm CREAtinine Measurements project) between 2006 and 2021 was conducted. The cohort captured 1,179,501 unique individuals (80% of the population in the region) with 6,914,993 repeated annual eGFR measurements. After computing eGFR distributions by age and sex, cause-specific Cox regressions evaluated the associations between eGFR percentiles and risks of kidney failure with replacement therapy (KFRT) and death. RESULTS: Median eGFR (2009 CKD-EPI) was lower at higher age, from 104-106 ml/min per 1.73 m2 (men-women) at age 40 to 45-50 ml/min per 1.73 m2 at age 100. Exclusion of individuals with selected comorbid conditions or adjustment for the non-tested population had minimal impact on eGFR distributions. Compared to the central percentiles (47.5-52.5th), eGFR percentiles below the 25th were significantly associated with increased risk of KFRT, and both low and high eGFR percentiles were associated with increased mortality. Associations were consistent across age groups. Among 421,547 individuals with eGFR 60 ml/min per 1.73 m2 or more who were below the 25th percentile, only 24% underwent albuminuria/proteinuria testing in the adjacent year and could have benefited from additional diagnostic work-up. CONCLUSIONS: Our study shows that eGFR values below the 25th percentile of the population distribution are associated with increased risks of kidney failure and death. Population-based eGFR charts may complement current automatic reporting systems and provide opportunities for early identification and primary prevention of CKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Yang Y, Creon A, Levey AS, et al. Population-based estimated Glomerular Filtration Rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease. Kidney Int. 2026. PMID: 41543464. doi:10.1016/j.kint.2025.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。